JP2019533450A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019533450A5 JP2019533450A5 JP2019521099A JP2019521099A JP2019533450A5 JP 2019533450 A5 JP2019533450 A5 JP 2019533450A5 JP 2019521099 A JP2019521099 A JP 2019521099A JP 2019521099 A JP2019521099 A JP 2019521099A JP 2019533450 A5 JP2019533450 A5 JP 2019533450A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- isoform
- composition according
- cells
- surface protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023105962A JP7676472B2 (ja) | 2016-11-02 | 2023-06-28 | 細胞療法に使用するための、免疫学的に識別できる細胞表面変異体 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16196860.7 | 2016-11-02 | ||
| EP16196860 | 2016-11-02 | ||
| EP16196858.1 | 2016-11-02 | ||
| EP16196858 | 2016-11-02 | ||
| EPPCT/EP2017/059799 | 2017-04-25 | ||
| PCT/EP2017/059799 WO2017186718A1 (en) | 2016-04-25 | 2017-04-25 | Allele editing and applications thereof |
| EP17197820 | 2017-10-23 | ||
| EP17197820.8 | 2017-10-23 | ||
| PCT/EP2017/077826 WO2018083071A1 (en) | 2016-11-02 | 2017-10-30 | Immunologically discernible cell surface variants for use in cell therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023105962A Division JP7676472B2 (ja) | 2016-11-02 | 2023-06-28 | 細胞療法に使用するための、免疫学的に識別できる細胞表面変異体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019533450A JP2019533450A (ja) | 2019-11-21 |
| JP2019533450A5 true JP2019533450A5 (cg-RX-API-DMAC7.html) | 2020-12-03 |
| JP7305539B2 JP7305539B2 (ja) | 2023-07-10 |
Family
ID=62075802
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019521099A Active JP7305539B2 (ja) | 2016-11-02 | 2017-10-30 | 細胞療法に使用するための、免疫学的に識別できる細胞表面変異体 |
| JP2023105962A Active JP7676472B2 (ja) | 2016-11-02 | 2023-06-28 | 細胞療法に使用するための、免疫学的に識別できる細胞表面変異体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023105962A Active JP7676472B2 (ja) | 2016-11-02 | 2023-06-28 | 細胞療法に使用するための、免疫学的に識別できる細胞表面変異体 |
Country Status (21)
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201708257UA (en) | 2015-04-06 | 2017-11-29 | Subdomain Llc | De novo binding domain containing polypeptides and uses thereof |
| IL258491B2 (en) | 2015-10-16 | 2023-09-01 | Univ Columbia | Preparations and methods for inhibiting antigens of a particular lineage |
| EP3448995A1 (en) * | 2016-04-25 | 2019-03-06 | Universität Basel | Allele editing and applications thereof |
| ES3024357T3 (en) * | 2017-02-17 | 2025-06-04 | Purdue Research Foundation | Targeted ligand-payload based drug delivery for cell therapy |
| KR102709603B1 (ko) | 2017-02-28 | 2024-09-27 | 보르 바이오파마 인크. | 계통 특이적 단백질의 억제를 위한 조성물 및 방법 |
| US11464803B2 (en) | 2017-11-14 | 2022-10-11 | Arcellx, Inc. | D-domain containing polypeptides and uses thereof |
| AU2018368431B2 (en) | 2017-11-14 | 2024-03-21 | Arcellx, Inc. | Multifunctional immune cell therapies |
| SI3710067T1 (sl) | 2017-11-14 | 2026-01-30 | Arcellx, Inc. | Polipeptidi, ki vsebujejo D-domeno, in njihova uporaba |
| WO2019217942A1 (en) | 2018-05-11 | 2019-11-14 | Beam Therapeutics Inc. | Methods of substituting pathogenic amino acids using programmable base editor systems |
| CN112654710A (zh) | 2018-05-16 | 2021-04-13 | 辛瑟高公司 | 用于指导rna设计和使用的方法和系统 |
| ES3061216T3 (en) | 2018-06-29 | 2026-03-31 | Hope City | Cd6 targeted chimeric antigen receptors for treatment of certain autoimmune disorders |
| CA3110837A1 (en) | 2018-08-28 | 2020-03-05 | Vor Biopharma Inc. | Genetically engineered hematopoietic stem cells and uses thereof |
| US20220160870A1 (en) * | 2018-08-28 | 2022-05-26 | Roche Innovation Center Copenhagen A/S | Neoantigen engineering using splice modulating compounds |
| EP3908372A1 (en) * | 2019-01-13 | 2021-11-17 | Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. | Antibodies specific to human nectin-2 |
| KR102689877B1 (ko) * | 2019-11-28 | 2024-08-01 | 주식회사 센트릭스바이오 | CD300c 항원 또는 그의 수용체에 특이적으로 결합하는 키메라 항원 수용체 |
| US12616734B2 (en) | 2019-11-28 | 2026-05-05 | CentricsBio, Inc. | Chimeric antigen receptor specifically binding to cd 300C antigen or receptor thereof |
| US20230076643A1 (en) * | 2019-12-30 | 2023-03-09 | City Of Hope | Methods of making and using regulatory t cells and effector t cells having chimeric antigen receptors targeted to cd6, cd19, and/or an il-13r for treatment of autoimmune disorders and cancers |
| KR102347797B1 (ko) * | 2020-03-03 | 2022-01-07 | 한국과학기술원 | 대식세포 세포 표면 항원 및 이의 다양한 용도 |
| EP4126243A4 (en) * | 2020-03-27 | 2024-06-12 | The Trustees of Indiana University | Immunotherapeutic targets in multiple myeloma and methods for their identification |
| AU2021413252A1 (en) * | 2020-12-31 | 2023-06-08 | Vor Biopharma Inc. | Compositions and methods for cd34 gene modification |
| WO2022150831A1 (en) * | 2021-01-07 | 2022-07-14 | Innovative Cellular Therapeutics Holdings, Ltd. | Car cells and polyspecific binding molecules for treating solid tumor |
| CN112852875B (zh) * | 2021-02-26 | 2022-10-21 | 福建省立医院 | 示踪肿瘤T淋巴细胞浸润的CD3e转基因小鼠模型的构建方法 |
| CN113125754A (zh) * | 2021-04-16 | 2021-07-16 | 浙江普罗亭健康科技有限公司 | 一种用于监测人体免疫状态的23抗体试剂盒及应用 |
| CN113125755A (zh) * | 2021-04-16 | 2021-07-16 | 浙江普罗亭健康科技有限公司 | 一种用于监测人体免疫状态的9抗体试剂盒及应用 |
| CN113109575A (zh) * | 2021-04-16 | 2021-07-13 | 浙江普罗亭健康科技有限公司 | 一种用于监测人体免疫状态的40抗体试剂盒及应用 |
| CN113125718A (zh) * | 2021-04-16 | 2021-07-16 | 浙江普罗亭健康科技有限公司 | 一种用于监测人体免疫状态的45抗体试剂盒及应用 |
| CN113125733A (zh) * | 2021-04-16 | 2021-07-16 | 浙江普罗亭健康科技有限公司 | 一种用于监测人体免疫状态的42抗体试剂盒及应用 |
| WO2022246764A1 (zh) * | 2021-05-27 | 2022-12-01 | 中科蓝华(广州)生物医药技术有限公司 | 一种分析cd303+树突状细胞亚群表型和功能的方法及试剂盒 |
| WO2023283585A2 (en) | 2021-07-06 | 2023-01-12 | Vor Biopharma Inc. | Inhibitor oligonucleotides and methods of use thereof |
| EP4381062A1 (en) | 2021-08-02 | 2024-06-12 | Vor Biopharma Inc. | Compositions and methods for gene modification |
| EP4380693A1 (en) | 2021-08-06 | 2024-06-12 | Universität Basel | Discernible cell surface protein variants for use in cell therapy |
| IL313568A (en) | 2021-12-16 | 2024-08-01 | Universit?T Basel | Distinct cell membrane protein variants of CD117 for use in cellular therapy |
| CA3240875A1 (en) | 2021-12-23 | 2023-06-29 | Stefanie Urlinger | Discernible cell surface protein variants of cd45 for use in cell therapy |
| CN114292830B (zh) * | 2021-12-31 | 2024-05-03 | 复旦大学 | 蛋白SaCas9的抗原表位及其在基因编辑中的应用 |
| WO2024015925A2 (en) * | 2022-07-13 | 2024-01-18 | Vor Biopharma Inc. | Compositions and methods for artificial protospacer adjacent motif (pam) generation |
| WO2024073751A1 (en) | 2022-09-29 | 2024-04-04 | Vor Biopharma Inc. | Methods and compositions for gene modification and enrichment |
| EP4611807A4 (en) * | 2022-11-04 | 2026-07-29 | Univ Leland Stanford Junior | REBALANCING OF THE IMMUNE SYSTEM BY DEPLOYMENT OF HEMATOPOIETIC STEM CELLS ORIENTED TO MYELOID PRODUCTION |
| CN116153401B (zh) * | 2023-01-07 | 2024-01-05 | 杭州链康医学检验实验室有限公司 | 基于pdx的单细胞转录组数据分析方法、系统、设备和介质 |
| JP2026516593A (ja) | 2023-04-03 | 2026-05-26 | ウニバズィテート バーゼル | 細胞治療に使用するためのcd33の識別可能な表面タンパク質変異体 |
| EP4753751A1 (en) | 2023-08-04 | 2026-06-10 | Cimeio Therapeutics AG | Discernible cell surface protein variants of cd52 for use in cell therapy |
| WO2025132801A1 (en) | 2023-12-19 | 2025-06-26 | Cimeio Therapeutics Ag | Discernible protein variants of bcl-2 for use in cell therapy |
| CN120738344A (zh) * | 2025-08-26 | 2025-10-03 | 北京康美天鸿生物科技有限公司 | 检测地中海贫血基因突变的引物组及其应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002240745A1 (en) * | 2001-03-07 | 2002-09-19 | Andre Schuh | Diagnosis and treatment of blood disorders |
| EP1674479A1 (en) * | 2004-12-22 | 2006-06-28 | Memorial Sloan-Kettering Cancer Center | Modulation of Fc Gamma receptors for optimizing immunotherapy |
| WO2007087453A2 (en) * | 2006-01-27 | 2007-08-02 | Cellerant Therapeutics, Inc. | Compositions and methods for treating haematological proliferative disorders |
| EP3255061B1 (en) * | 2006-11-03 | 2021-06-16 | The Board of Trustees of the Leland Stanford Junior University | Selective immunodepletion of endogenous stem cell niche for engraftment |
| US8697846B2 (en) * | 2007-08-15 | 2014-04-15 | Emory University | Methods of making monoclonal antibodies using fusion-peptide epitope adoptive transfer (F-PEAT) technology |
| JP5688734B2 (ja) * | 2008-12-12 | 2015-03-25 | 国立大学法人 東京大学 | 移植片対腫瘍効果を保存した免疫学的再構築促進剤または感染症予防剤 |
| DK3363902T3 (da) * | 2012-12-06 | 2020-01-02 | Sigma Aldrich Co Llc | Crispr-baseret genommodifikation og -regulering |
| CN111363047A (zh) * | 2013-03-12 | 2020-07-03 | 分子模板公司 | 用于引起细胞内化的cd20结合免疫毒素及其使用方法 |
| EP3569253A1 (en) * | 2013-06-05 | 2019-11-20 | Bellicum Pharmaceuticals, Inc. | Methods for inducing partial apoptosis using caspase polypeptides |
| KR20160020554A (ko) * | 2013-06-17 | 2016-02-23 | 슈 생-쥐스땡 | 척추측만 개체의 세포에서 gipcr 신호전달을 증가시키는 방법 |
| WO2016014837A1 (en) * | 2014-07-25 | 2016-01-28 | Sangamo Biosciences, Inc. | Gene editing for hiv gene therapy |
| US10201606B2 (en) * | 2014-11-26 | 2019-02-12 | Miltenyi Biotec Gmbh | Combination immunotherapy of antigen-recognizing receptors and hematopoietic cells for the treatment of diseases |
| HK1256681A1 (zh) * | 2015-04-06 | 2019-10-04 | President And Fellows Of Harvard College | 用於非清髓性预处理的组合物和方法 |
| EP3370741B1 (en) * | 2015-11-04 | 2025-10-08 | The Trustees of the University of Pennsylvania | Methods and compositions for gene editing in hematopoietic stem cells |
| JP2019508037A (ja) * | 2016-02-16 | 2019-03-28 | イェール ユニバーシティーYale Universit | 標的化遺伝子編集を増強するための組成物およびその使用方法 |
| IL313038A (en) * | 2016-03-14 | 2024-07-01 | Editas Medicine Inc | Crispr/cas-related methods and compositions for treating beta hemoglobinopathies |
| EP3448995A1 (en) * | 2016-04-25 | 2019-03-06 | Universität Basel | Allele editing and applications thereof |
-
2017
- 2017-10-30 US US16/346,185 patent/US20190365806A1/en active Pending
- 2017-10-30 DK DK17797585.1T patent/DK3535392T3/da active
- 2017-10-30 LT LTEPPCT/EP2017/077826T patent/LT3535392T/lt unknown
- 2017-10-30 IL IL266362A patent/IL266362B2/en unknown
- 2017-10-30 EP EP17797585.1A patent/EP3535392B1/en active Active
- 2017-10-30 KR KR1020247009264A patent/KR20240043810A/ko active Pending
- 2017-10-30 CN CN201780067985.1A patent/CN110191948A/zh active Pending
- 2017-10-30 PL PL17797585.1T patent/PL3535392T3/pl unknown
- 2017-10-30 WO PCT/EP2017/077826 patent/WO2018083071A1/en not_active Ceased
- 2017-10-30 ES ES17797585T patent/ES2977969T3/es active Active
- 2017-10-30 SI SI201731518T patent/SI3535392T1/sl unknown
- 2017-10-30 EP EP24155910.3A patent/EP4360639A3/en active Pending
- 2017-10-30 HU HUE17797585A patent/HUE067685T2/hu unknown
- 2017-10-30 FI FIEP17797585.1T patent/FI3535392T3/fi active
- 2017-10-30 AU AU2017355218A patent/AU2017355218B2/en active Active
- 2017-10-30 CA CA3041582A patent/CA3041582A1/en active Pending
- 2017-10-30 MX MX2019005125A patent/MX2019005125A/es unknown
- 2017-10-30 KR KR1020197015826A patent/KR20190072639A/ko not_active Ceased
- 2017-10-30 JP JP2019521099A patent/JP7305539B2/ja active Active
- 2017-10-30 BR BR112019008975-6A patent/BR112019008975A2/pt active IP Right Grant
- 2017-10-30 HR HRP20240842TT patent/HRP20240842T1/hr unknown
- 2017-10-30 SG SG11201903454VA patent/SG11201903454VA/en unknown
-
2019
- 2019-04-16 ZA ZA2019/02426A patent/ZA201902426B/en unknown
-
2023
- 2023-06-28 JP JP2023105962A patent/JP7676472B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023126852A5 (cg-RX-API-DMAC7.html) | ||
| HRP20240842T1 (hr) | Imunološki uočljive varijante stanične površine za upotrebu u staničnoj terapiji | |
| JP2023515199A5 (cg-RX-API-DMAC7.html) | ||
| IL295897A (en) | Materials and methods for modulating an immune response | |
| HRP20200251T1 (hr) | Proizvodnja i korištenje vitro-sintetizirane ssrna za uvođenje u ćelije sisavaca za proizvodnju biološkog ili biokemijskog učinka | |
| JP2025517657A5 (cg-RX-API-DMAC7.html) | ||
| JP2024506682A5 (cg-RX-API-DMAC7.html) | ||
| JP2025513879A5 (cg-RX-API-DMAC7.html) | ||
| JP2023537534A5 (cg-RX-API-DMAC7.html) | ||
| JP2004528806A5 (cg-RX-API-DMAC7.html) | ||
| JP2017200474A5 (cg-RX-API-DMAC7.html) | ||
| JP2022534813A (ja) | Cd33改変のための組成物および方法 | |
| US20240408234A1 (en) | Compositions and methods for multiplex base editing in hematopoietic cells | |
| WO2022061115A1 (en) | Compositions and methods for cd7 modification | |
| US20230364233A1 (en) | Compositions and methods for cd6 modification | |
| US20240417755A1 (en) | Fusion polypeptides for genetic editing and methods of use thereof | |
| WO2022217086A1 (en) | Photocleavable guide rnas and methods of use thereof | |
| EP4430186A1 (en) | Compositions and methods for erm2 modification | |
| US20240384304A1 (en) | Inhibitor oligonucleotides and methods of use thereof | |
| AU2024369017A1 (en) | SIRPα ENGAGER CELLS | |
| RU2793803C2 (ru) | Иммунологически отличимые варианты поверхности клеток для применения в клеточной терапии | |
| HK40014655A (en) | Immunologically discernible cell surface variants for use in cell therapy | |
| HK40014655B (en) | Immunologically discernible cell surface variants for use in cell therapy |